These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 7594519

  • 1. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
    Brochu S, Baron C, Hétu F, Roy DC, Perreault C.
    J Immunol; 1995 Dec 01; 155(11):5104-14. PubMed ID: 7594519
    [Abstract] [Full Text] [Related]

  • 2. Studies of immunologic tolerance to host minor histocompatibility antigens following allogeneic bone marrow transplantation in mice.
    Perreault C, Allard A, Brochu S, Poupart C, Fontaine P, Bélanger R, Gyger M.
    Bone Marrow Transplant; 1990 Aug 01; 6(2):127-35. PubMed ID: 2145050
    [Abstract] [Full Text] [Related]

  • 3. Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease.
    Friedman TM, Gilbert M, Briggs C, Korngold R.
    J Immunol; 1998 Jul 01; 161(1):41-8. PubMed ID: 9647205
    [Abstract] [Full Text] [Related]

  • 4. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC, Friedman TM, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2004 Feb 01; 10(2):91-105. PubMed ID: 14750075
    [Abstract] [Full Text] [Related]

  • 5. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD, Becker EE, LaBelle JL, Truitt RL.
    J Immunol; 1999 Dec 15; 163(12):6479-87. PubMed ID: 10586039
    [Abstract] [Full Text] [Related]

  • 6. Evolution of responding CD4+ and CD8+ T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens.
    Friedman TM, Jones SC, Statton D, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2004 Apr 15; 10(4):224-35. PubMed ID: 15077221
    [Abstract] [Full Text] [Related]

  • 7. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR, Majewski D, Hanson G.
    Biol Blood Marrow Transplant; 1999 Apr 15; 5(4):222-30. PubMed ID: 10465102
    [Abstract] [Full Text] [Related]

  • 8. Immunodominant CD4+ T cell receptor Vbeta repertoires involved in graft-versus-host disease responses to minor histocompatibility antigens.
    Berger MA, Korngold R.
    J Immunol; 1997 Jul 01; 159(1):77-85. PubMed ID: 9200441
    [Abstract] [Full Text] [Related]

  • 9. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M, Wettstein PJ, Korngold R.
    Transplantation; 1994 Apr 15; 57(7):1095-102. PubMed ID: 7909395
    [Abstract] [Full Text] [Related]

  • 10. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
    Jones MS, Riley R, Hamilton BL, Paupe J, Perez D, Levy RB.
    Bone Marrow Transplant; 1994 Nov 15; 14(5):725-35. PubMed ID: 7889005
    [Abstract] [Full Text] [Related]

  • 11. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
    Friedman TM, Statton D, Jones SC, Berger MA, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2001 Nov 15; 7(1):2-13. PubMed ID: 11215694
    [Abstract] [Full Text] [Related]

  • 12. Inter-strain graft-vs.-host disease T-cell responses to immunodominant minor histocompatibility antigens.
    Korngold R, Leighton C, Mobraaten LE, Berger MA.
    Biol Blood Marrow Transplant; 1997 Jun 15; 3(2):57-64. PubMed ID: 9267665
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of various T cell subtypes on GVHD in a murine model for MHC-matched unrelated donor transplant.
    OKunewick JP, Kociban DL, Buffo MJ.
    Bone Marrow Transplant; 1990 Mar 15; 5(3):145-52. PubMed ID: 1691938
    [Abstract] [Full Text] [Related]

  • 14. Tolerance to host minor histocompatibility antigens after allogenic bone marrow transplantation. Specific donor-host unresponsiveness is maintained by peripheral tolerizing cells.
    Brochu S, Roy DC, Perreault C.
    J Immunol; 1992 Nov 15; 149(10):3135-41. PubMed ID: 1431092
    [Abstract] [Full Text] [Related]

  • 15. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T, Eto M, Lin T, Nishimura Y, Kong YY, Nomoto K, Nomoto K.
    J Immunol; 1994 Nov 01; 153(9):4311-20. PubMed ID: 7930630
    [Abstract] [Full Text] [Related]

  • 16. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 01; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

  • 17. Oligoclonal expansion of T cell receptor V beta 2 and 3 cells in the livers of mice with graft-versus-host disease.
    Chen W, Howell CD.
    Hepatology; 2002 Jan 01; 35(1):23-9. PubMed ID: 11786956
    [Abstract] [Full Text] [Related]

  • 18. Bone marrow-derived cells are essential for intrathymic deletion of self-reactive T cells in both the host- and donor-derived thymocytes of fully allogeneic bone marrow chimeras.
    Yoshikai Y, Ogimoto M, Matsuzaki G, Nomoto K.
    J Immunol; 1990 Jul 15; 145(2):505-9. PubMed ID: 2114441
    [Abstract] [Full Text] [Related]

  • 19. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S, Kim JC, Whitaker-Menezes D, Murphy GF, Friedman TM, Korngold R.
    Biol Blood Marrow Transplant; 2004 Oct 15; 10(10):669-80. PubMed ID: 15389433
    [Abstract] [Full Text] [Related]

  • 20. Clonal analysis of murine graft-vs-host disease. I. Phenotypic and functional analysis of T lymphocyte clones.
    Parkman R.
    J Immunol; 1986 May 15; 136(10):3543-8. PubMed ID: 2871104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.